Latest Auditing News

Yowie Group has entered FY27 with US$71,000 in cash, a 35% drop in US gross sales and a fully drawn A$4 million working capital facility. The confectionery maker is pursuing an approximately A$6 million two-tranche capital raising while its ASX quotation remains suspended.

Caravel Minerals is moving its 100%-owned Caravel Copper Project towards a Definitive Feasibility Study due in the fourth quarter, but the annual report also flags a material uncertainty over its ability to continue as a going concern. The company remains pre-revenue, with approvals, project finance and key commercial arrangements still incomplete.

Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.

Mindax ended FY2026 with just A$83,116 in cash and a A$2.49 million loss before tax, prompting its auditor to highlight material uncertainty over the company’s ability to continue as a going concern. Post-year-end funding has lifted cash to A$4.079 million, although much of that support remains tied to convertible debt and approvals.

Transmetro Corporation (ASX:TCO) delivered a 50% increase in FY2026 net profit to A$4.49 million, while cash rose to A$13.94 million and the fully franked dividend increased to 6 cents per share. The debt-free hotel operator is preparing to open Metro Hotel Martin Place Sydney and support a major refurbishment of its 220-room Marlow property.

American Rare Earths has moved Halleck Creek closer to development, expanding the proposed Cowboy State Mine, completing 18 feasibility-stage drill holes and beginning pilot plant processing. But with A$11.0 million in cash and an estimated 1.44 quarters of funding at current outgoings, the next phase will likely require fresh capital or another funding source.

Mesoblast has posted a 44% rise in first-quarter Ryoncil revenue to US$28 million while sharply reducing operating cash use. The biotechnology company also completed treatment in its 350-patient chronic low back pain trial and received FDA confirmation that a heart-failure BLA filing may proceed.

Cullen Resources has extended shallow gold-silver-copper targets at Yardilla and identified a new conductor for drilling at North Tuckabianna. But with $176,000 in cash and an estimated 0.81 quarters of funding, the next exploration steps will likely depend on new financing or asset sales.

Challenger has used its 2026 AGM to showcase stronger earnings, record annuity sales and a substantial capital buffer while keeping discussions open with TAL Daiichi Life over its $11.80-per-share approach. The board still does not consider the proposal sufficient to recommend to shareholders.

Magontec’s nine-month revenue rose 28.9% to A$59.4 million as stronger electronic anode sales and a recovery in Metals lifted gross profit to A$12.8 million. The turnaround is generating cash before working-capital movements, but Chinese demand, European automotive weakness and near-term debt maturities remain live risks.

Syrah Resources delivered a stronger Balama quarter and began ramping Vidalia’s US anode-material facility towards commercial sales. But higher cost guidance, negative operating cash flow and unresolved loan defaults leave the balance sheet as the central risk.

AVADA Group’s FY27 first-quarter customer receipts rose 38% to A$66.4 million, but cash conversion remained tight after A$5.1 million in Payday Super and prior-period ATO payments. The traffic management operator ended September with A$3.31 million in cash and A$13.84 million of unused facilities.